This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
BACKGROUND AND PURPOSE: Recent advances in fetal MR imaging technology have enabled acquisition of diagnostic images in the early second trimester. Interpretation of these examinations is limited by a lack of familiarity with the developmental changes that occur during these early stages of growth. This study aimed to characterize normal fetal brain growth between the 12th and 20th weeks of gestational age.
MATERIALS AND METHODS: This study was conducted as an observational retrospective analysis. Data were obtained from a tertiary care center’s PACS database. All fetuses included had late fetal MR imaging (>20 weeks) or postnatal MR imaging, which confirmed normality. Each MR image was manually segmented, with ROIs placed to calculate the volume of the supratentorial parenchyma, brainstem, cerebellum, ventricular CSF, and extra-axial CSF. A linear regression analysis was used to evaluate gestational age as a predictor of the volume of each structure.
RESULTS: Thirty-one subjects with a mean gestational age of 17.23 weeks (range, 12–19 weeks) were studied. There was a positive, significant association between gestational age and intracranial, supratentorial parenchyma; brainstem cerebellum; intraventricular CSF; and extra-axial CSF volumes (P < .001). Growth was fastest in the supratentorial parenchyma and extra-axial CSF. Fetal sex was not associated with the volume in any of the ROIs.
CONCLUSIONS: This study demonstrates distinct trajectories for the major compartments of the fetal brain in the early second trimester. The fastest growth rates were observed in the supratentorial brain and extra-axial CSF.
ABBREVIATION:
- GA
- gestational age
Footnotes
J.A. Estroff and C. Jaimes are co-senior authors.
This work was supported by the American Roentgen Ray Society Scholarship; Career Development Award from the Office of Faculty Development at Boston Children’s Hospital; National Institute of Neurological Disorders and Stroke, grant/award Nos. R01EB031849, R01EB032366, R01HD109395, R01NS106030; National Institutes of Health Office of the Director, grant/award No. S10OD0250111; Rosamund Stone Zander Translational Neuroscience Center, Boston Children's Hospital; National Institute of Biomedical Imaging and Bioengineering; Eunice Kennedy Shriver National Institute of Child Health.
Disclosure forms provided by the authors are available with the full text and PDF of this article at www.ajnr.org.
- © 2023 by American Journal of Neuroradiology